Postpupillary block characteristics
| Patient No | Medical intervention | Surgical intervention | IOP final (mm Hg) | Visual acuity after PB relieved |
|---|---|---|---|---|
| AC = anterior chamber. | ||||
| 1 | Topical β blockers | YAG laser iridotomy | 6 | 20/300 |
| Topical and systemic carbonic anhydrase inhibitors | ||||
| Topical α adrenergic agonists | ||||
| Hyperosmotic agents | ||||
| Cycloplegia | ||||
| Topical steroids | ||||
| 2 | Topical β blockers | YAG laser iridotomy | 10 | 20/80 |
| Systemic carbonic anhydrase inhibitors | AC washout (for fibrin) | |||
| Hyperosmotic agents | ||||
| Cycloplegia | ||||
| Topical steroids | ||||
| 3 | Topical β blockers | YAG laser iridotomy (×2) | 6 | 20/150 |
| Topical α adrenergic agonists | ||||
| Xalatan | ||||
| 4 RE | Topical β1 selective blockers | YAG laser iridotomy (×3) | 30 | 20/120 |
| Topical α adrenergic agonists | ||||
| Pilocarpine 2% | ||||
| Systemic carbonic anhydrase inhibitors | ||||
| Cycloplegia | ||||
| 4 LE | Topical β2 selective blockers | YAG laser iridotomy | 28 | 1/24 |
| Topical α adrenergic agonists | Anterior vitrectomy+surgical iridectomy (×2) | |||
| Systemic carbonic anhydrase inhibitors | Cyclodiode | |||
| 5 | Topical β blockers | YAG laser iridotomy | 8 | 20/30 |
| Pilocarpine 2% | ||||
| Systemic carbonic anhydrase inhibitors | ||||
| 6 | Topical β blockers | YAG laser iridotomy (×2) | 18 | 20/150 |
| Topical α adrenergic agonists | YAG laser capsulotomy | |||
| Topical carbonic anhydrase inhibitors | ||||